Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

54.6K
Overview
54.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccines01:21

Vaccines

55
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infection.

Cell reports·2026
Same author

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Immunity·2026
Same author

Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumors.

Biomaterials·2026
Same author

A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies.

Npj viruses·2026
Same author

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

Frontiers in immunology·2026
Same journal

Redefining the Entamoeba landscape with next-generation sequencing: Implications for diagnosis and epidemiology.

Advances in parasitology·2026
Same journal

Parasite-associated microbiomes: An unseen microenvironment.

Advances in parasitology·2026
Same journal

Current status of -omics research in platyhelminth parasites of teleost fish.

Advances in parasitology·2026
Same journal

Key discoveries from research in anisakiasis: From parasite biology to pathology in the human host.

Advances in parasitology·2025
Same journal

Hard to make and hard to take: Exploring the current and future barriers to the development and implementation of antipoverty vaccines in sub-Saharan Africa.

Advances in parasitology·2025
Same journal

Survival of the fittest: How Leishmania evades drug therapy.

Advances in parasitology·2025
See all related articles

Related Experiment Video

Updated: Apr 14, 2026

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.8K

Recent developments in malaria vaccinology.

Benedict R Halbroth1, Simon J Draper1

  • 1The Jenner Institute, University of Oxford, Oxford, UK.

Advances in Parasitology
|April 26, 2015
PubMed
Summary
This summary is machine-generated.

Developing a highly effective malaria vaccine is crucial for disease eradication. Recent advances show promising efficacy for new vaccines targeting Plasmodium falciparum and Plasmodium vivax.

Keywords:
AdjuvantBlood-stageLiver-stageMalariaPlasmodiumSporozoiteTransmission-blockingVaccine

More Related Videos

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.8K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.6K

Related Experiment Videos

Last Updated: Apr 14, 2026

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.8K
Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.8K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

18.6K

Area of Science:

  • Malariology and Vaccinology
  • Parasitic Disease Control
  • Infectious Disease Research

Background:

  • Malaria remains a significant global health challenge, necessitating advanced control strategies.
  • The first-generation RTS,S malaria vaccine demonstrated moderate efficacy, highlighting the need for improved interventions.
  • The 2030 Malaria Vaccine Technology Roadmap mandates higher efficacy (75%) and transmission-blocking capabilities for next-generation vaccines.

Purpose of the Study:

  • To review recent advancements in malaria vaccine development.
  • To discuss novel approaches targeting different parasite stages and transmission.
  • To assess the feasibility of developing highly effective multi-component, multi-stage malaria vaccines.

Main Methods:

  • Review of recent scientific literature and clinical trial data on malaria vaccines.
  • Analysis of emerging immunisation strategies, including whole-parasite and subunit approaches.
  • Evaluation of new vaccine candidates entering clinical development for blood-stage and transmission-blocking immunity.

Main Results:

  • Whole-parasite immunisation and pre-erythrocytic subunit vaccine combinations show high efficacy.
  • New blood-stage and transmission-blocking vaccine components are progressing through clinical trials.
  • Development of a multi-component, multi-stage subunit vaccine is becoming a realistic goal.

Conclusions:

  • Significant progress has been made in malaria vaccinology, moving towards more effective vaccines.
  • Next-generation malaria vaccines are expected to achieve higher efficacy and prevent transmission.
  • Integrated approaches combining different vaccine strategies hold promise for malaria eradication.